People who maintain ideal cardiovascular heath have a low lifetime risk of cardiovascular
disease. Therefore, encouraging people to achieve ideal cardiovascular health represents …

The role of lipids and lipoproteins as risk factors for cardiovascular disease (CVD) is well
established. Although CVD remains as the leading cause of mortality in adults, there is a …

In the 21st century, atherosclerosis is well established as the leading cause of death in most
industrialized nations. 5 Large population-based studies have identified several risk factors …

The preponderance of evidence confirms the importance of aggressive lipid modification in
patients at risk for coronary heart disease (CHD). However, data suggest that this …

Primary prevention of incident atherosclerotic cardiovascular disease (ASCVD) as well as
decreasing the risk of future events in those with established atherosclerosis is critical from a …

Lipid Management to Prevent CVD Management of serum cholesterol level is a central
objective in preventing cardiovascular events. Current guidelines recommend calculation of …

Cardiovascular disease is the leading cause of death in the United States. In 2010, the
Centers for Disease Control and Prevention estimated that $444 billion was spent on …

Atherosclerotic cardiovascular disease (ASCVD) is epidemic throughout the world and is
etiologic for such acute cardiovascular events as myocardial infarction, ischemic stroke …

Atherosclerotic cardiovascular disease is now the major global cause of death, despite
reductions in CVD deaths in developed societies. Dyslipidemias are a major contributor, but …

The treatment of dyslipidemia continues to be a dynamic and controversial topic. Even the
most appropriate therapeutic range for lipid levels—including that of triglycerides and low …